ICON Return on Tangible Equity 2010-2025 | ICLR
Current and historical return on tangible equity values for ICON (ICLR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| ICON Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $0.76B | $-3.07B | -24.99% |
| 2024-12-31 | $0.79B | $-3.09B | -25.51% |
| 2024-09-30 | $0.75B | $-2.92B | -23.07% |
| 2024-06-30 | $0.71B | $-3.06B | -20.41% |
| 2024-03-31 | $0.68B | $-3.34B | -18.00% |
| 2023-12-31 | $0.61B | $-3.64B | -15.01% |
| 2023-09-30 | $0.51B | $-3.96B | -11.78% |
| 2023-06-30 | $0.51B | $-4.25B | -10.98% |
| 2023-03-31 | $0.51B | $-4.49B | -10.37% |
| 2022-12-31 | $0.51B | $-4.75B | -9.74% |
| 2022-09-30 | $0.46B | $-5.10B | -8.57% |
| 2022-06-30 | $0.21B | $-5.33B | -3.76% |
| 2022-03-31 | $0.17B | $-5.55B | -4.21% |
| 2021-12-31 | $0.15B | $-5.68B | -6.46% |
| 2021-09-30 | $0.18B | $-5.78B | -24.13% |
| 2021-06-30 | $0.36B | $1.04B | 40.92% |
| 2021-03-31 | $0.34B | $0.95B | 43.26% |
| 2020-12-31 | $0.33B | $0.85B | 48.95% |
| 2020-09-30 | $0.33B | $0.73B | 51.32% |
| 2020-06-30 | $0.33B | $0.60B | 54.60% |
| 2020-03-31 | $0.38B | $0.54B | 61.89% |
| 2019-12-31 | $0.37B | $0.71B | 60.37% |
| 2019-09-30 | $0.36B | $0.59B | 62.72% |
| 2019-06-30 | $0.35B | $0.60B | 63.04% |
| 2019-03-31 | $0.33B | $0.58B | 64.69% |
| 2018-12-31 | $0.32B | $0.54B | 70.10% |
| 2018-09-30 | $0.31B | $0.52B | 74.23% |
| 2018-06-30 | $0.30B | $0.42B | 83.16% |
| 2018-03-31 | $0.29B | $0.36B | 84.96% |
| 2017-12-31 | $0.28B | $0.35B | 88.57% |
| 2017-09-30 | $0.28B | $0.29B | 95.38% |
| 2017-06-30 | $0.27B | $0.36B | 91.03% |
| 2017-03-31 | $0.27B | $0.27B | 97.30% |
| 2016-12-31 | $0.26B | $0.27B | 102.34% |
| 2016-09-30 | $0.25B | $0.30B | 117.07% |
| 2016-06-30 | $0.25B | $0.26B | 123.76% |
| 2016-03-31 | $0.25B | $0.19B | 104.64% |
| 2015-12-31 | $0.24B | $0.11B | 84.34% |
| 2015-09-30 | $0.23B | $0.25B | 62.81% |
| 2015-06-30 | $0.22B | $0.40B | 51.23% |
| 2015-03-31 | $0.20B | $0.38B | 45.40% |
| 2014-12-31 | $0.18B | $0.44B | 36.90% |
| 2014-09-30 | $0.16B | $0.49B | 31.27% |
| 2014-06-30 | $0.14B | $0.46B | 27.29% |
| 2014-03-31 | $0.12B | $0.57B | 24.09% |
| 2013-12-31 | $0.10B | $0.52B | 22.87% |
| 2013-09-30 | $0.09B | $0.46B | 21.60% |
| 2013-06-30 | $0.08B | $0.42B | 20.33% |
| 2013-03-31 | $0.07B | $0.38B | 18.96% |
| 2012-12-31 | $0.06B | $0.41B | 16.67% |
| 2012-09-30 | $0.04B | $0.37B | 12.06% |
| 2012-06-30 | $0.02B | $0.34B | 6.15% |
| 2012-03-31 | $0.02B | $0.35B | 5.61% |
| 2011-12-31 | $0.02B | $0.40B | 5.01% |
| 2011-09-30 | $0.04B | $0.41B | 8.68% |
| 2011-06-30 | $0.06B | $0.49B | 13.28% |
| 2011-03-31 | $0.07B | $0.47B | 15.93% |
| 2010-12-31 | $0.09B | $0.49B | 19.61% |
| 2010-09-30 | $0.10B | $0.46B | 22.88% |
| 2010-06-30 | $0.10B | $0.42B | 25.45% |
| 2010-03-31 | $0.10B | $0.41B | 26.00% |
| 2009-12-31 | $0.10B | $0.39B | 27.78% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.023B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.921B | 26.99 |
| Elevance Health (ELV) | United States | $89.416B | 11.54 |
| CVS Health (CVS) | United States | $88.020B | 10.94 |
| Cencora (COR) | United States | $57.242B | 19.91 |
| DiDi Global (DIDIY) | China | $22.544B | 23.95 |
| Labcorp Holdings (LH) | United States | $22.119B | 17.94 |
| Natera (NTRA) | United States | $21.946B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.094B | 0.00 |
| Solventum (SOLV) | United States | $13.476B | 14.27 |
| CochLear (CHEOY) | Australia | $12.827B | 0.00 |
| Revvity (RVTY) | United States | $11.673B | 20.09 |
| Viatris (VTRS) | United States | $10.774B | 3.70 |
| Avantor (AVTR) | United States | $9.486B | 13.78 |
| Medpace Holdings (MEDP) | United States | $9.228B | 24.51 |
| HealthEquity (HQY) | United States | $8.897B | 38.97 |
| Sonic Healthcare (SKHHY) | Australia | $8.498B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.583B | 14.86 |
| Caris Life Sciences,�Inc (CAI) | $6.744B | 0.00 | |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.758B | 28.02 |
| BrightSpring Health Services (BTSG) | United States | $3.915B | 35.92 |
| Sotera Health (SHC) | United States | $3.250B | 18.47 |
| Surgery Partners (SGRY) | United States | $2.890B | 37.58 |
| Alignment Healthcare (ALHC) | United States | $2.811B | 0.00 |
| Concentras Parent (CON) | United States | $2.671B | 15.44 |
| Organon (OGN) | United States | $2.613B | 2.78 |
| GeneDx Holdings (WGS) | United States | $2.576B | 99.22 |
| PACS (PACS) | United States | $1.974B | 0.00 |
| Ardent Health (ARDT) | United States | $1.964B | 8.37 |
| Progyny (PGNY) | United States | $1.891B | 41.62 |
| Premier (PINC) | United States | $1.789B | 13.58 |
| GoodRx Holdings (GDRX) | United States | $1.772B | 35.43 |
| Teladoc Health (TDOC) | United States | $1.505B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.255B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.231B | 9.37 |
| CareDx (CDNA) | United States | $1.050B | 16.39 |
| Agilon Health (AGL) | United States | $0.985B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.842B | 7.88 |
| QDM (QDMI) | Hong Kong, SAR China | $0.776B | 0.00 |
| Nutex Health (NUTX) | United States | $0.732B | 11.09 |
| Embecta (EMBC) | United States | $0.600B | 4.04 |
| LifeMD (LFMD) | United States | $0.597B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.533B | 0.00 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| Omada Health (OMDA) | $0.470B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 10.48 |
| Sonida Senior Living (SNDA) | United States | $0.456B | 0.00 |
| Enhabit (EHAB) | United States | $0.399B | 32.83 |
| Performant Healthcare (PHLT) | United States | $0.322B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.296B | 0.00 |
| So-Young (SY) | China | $0.288B | 0.00 |
| Beauty Health (SKIN) | United States | $0.272B | 0.00 |
| Oncology Institute (TOI) | United States | $0.196B | 0.00 |
| DocGo (DCGO) | United States | $0.155B | 25.33 |
| Pheton Holdings (PTHL) | China | $0.121B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.098B | 0.00 |
| KindlyMD (NAKA) | United States | $0.082B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.045B | 0.00 |
| Biodesix (BDSX) | United States | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.030B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.029B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.020B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |